BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20970154)

  • 1. Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs.
    Agosto LM; Liszewski MK; Mexas A; Graf E; Pace M; Yu JJ; Bhandoola A; O'Doherty U
    Virology; 2011 Jan; 409(1):46-53. PubMed ID: 20970154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
    Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
    Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.
    Graf EH; Mexas AM; Yu JJ; Shaheen F; Liszewski MK; Di Mascio M; Migueles SA; Connors M; O'Doherty U
    PLoS Pathog; 2011 Feb; 7(2):e1001300. PubMed ID: 21383972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
    Pinzone MR; O'Doherty U
    Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
    Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
    J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.
    Jurriaans S; de Ronde A; Dekker J; Cornelissen M; Goudsmit J
    J Med Virol; 1995 Jan; 45(1):91-8. PubMed ID: 7714497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
    Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
    J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.
    Chun TW; Stuyver L; Mizell SB; Ehler LA; Mican JA; Baseler M; Lloyd AL; Nowak MA; Fauci AS
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13193-7. PubMed ID: 9371822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of viral reservoirs in HIV-1 infection.
    Blankson JN; Persaud D; Siliciano RF
    Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
    Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
    J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
    Carr JM; Cheney KM; Coolen C; Davis A; Shaw D; Ferguson W; Chang G; Higgins G; Burrell C; Li P
    J Clin Microbiol; 2007 Apr; 45(4):1288-97. PubMed ID: 17314225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
    Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
    J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR; Siliciano RF; Wilke CO
    BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.
    Eriksson S; Graf EH; Dahl V; Strain MC; Yukl SA; Lysenko ES; Bosch RJ; Lai J; Chioma S; Emad F; Abdel-Mohsen M; Hoh R; Hecht F; Hunt P; Somsouk M; Wong J; Johnston R; Siliciano RF; Richman DD; O'Doherty U; Palmer S; Deeks SG; Siliciano JD
    PLoS Pathog; 2013 Feb; 9(2):e1003174. PubMed ID: 23459007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART.
    Calcaterra S; Cappiello G; Di Caro A; Garbuglia AR; Benedetto A
    J Infect; 2001 Nov; 43(4):239-45. PubMed ID: 11869061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 integration landscape during latent and active infection.
    Cohn LB; Silva IT; Oliveira TY; Rosales RA; Parrish EH; Learn GH; Hahn BH; Czartoski JL; McElrath MJ; Lehmann C; Klein F; Caskey M; Walker BD; Siliciano JD; Siliciano RF; Jankovic M; Nussenzweig MC
    Cell; 2015 Jan; 160(3):420-32. PubMed ID: 25635456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.
    Blazkova J; Chun TW; Belay BW; Murray D; Justement JS; Funk EK; Nelson A; Hallahan CW; Moir S; Wender PA; Fauci AS
    J Infect Dis; 2012 Sep; 206(5):765-9. PubMed ID: 22732922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.